Securities

PCRX Investors Invited to Head Class Action Lawsuit Against Pacira BioSciences Over Alleged Securities Fraud

by

Investors in Pacira BioSciences, Inc., a New Jersey-based pharmaceutical company, have been granted the opportunity to lead a securities class action lawsuit over allegations of fraudulent activity. The lawsuit surrounds claims that Pacira misrepresented its financial status and the efficacy of certain products, thereby inflating its stocks artificially. The legal challenge roots from assertions that Pacira failed to disclose operational and business setbacks, particularly concerning the effectiveness and market acceptance of EXPAREL, a non-opioid pain management drug that is one of the company’s top products. Allegedly, the company made misleading statements or failed to provide … Read more

Investors Alert: Class Action Lawsuit Targets Innovative Industrial Properties Over Alleged Securities Fraud

by

NEW YORK — Levi & Korsinsky, LLP, a renowned legal firm, has announced a class action securities lawsuit on behalf of shareholders of Innovative Industrial Properties, Inc. (IIPR). The lawsuit pertains to individuals who invested in the company and may have experienced financial losses due to purported securities fraud during a specified period last year. The lawsuit targets claims that were made between February 27, 2024, and December 19, 2024, alleging that Innovative Industrial Properties failed to disclose material adverse facts about its business operations, specifically in its leasing operations. The legal complaint accuses the … Read more

Deadline Alert: Rosen Law Firm Announces March 10 Lead Plaintiff Deadline in Micron Technology Securities Class Action – Investors May Be Eligible for Compensation

by

NEW YORK — The Rosen Law Firm, a prominent global investor rights law firm, is calling attention to an upcoming deadline for the investors of Micron Technology, Inc. the public should note March 10, 2025, as the important lead plaintiff deadline for a class action lawsuit involving the purchase of common stock between September 28, 2023, and December 18, 2024. Investors who acquired Micron shares during this period may be eligible for compensation through a contingency fee arrangement, without needing to pay any out-of-pocket fees or costs. Those who purchased Micron common stock during the … Read more

Lawsuit Filed Against Crocs, Inc. Over Alleged Securities Law Violations, Claims Bleichmar Fonti & Auld LLP

by

New York — Bleichmar Fonti & Auld LLP, a prominent securities law firm, has initiated a lawsuit against footwear manufacturer Crocs, Inc., along with several of its top executives, citing potential transgressions of federal securities laws. This legal action, rooted in alleged improper practices in supply chain management and sales reporting, was recently filed in the U.S. District Court for the District of Delaware, identified as Carretta v. Crocs, Inc., et al., No. 25-cv-00096. The complaint focuses on violations under the Securities Exchange Act of 1934, particularly Sections 10(b) and 20(a), representing investors who acquired … Read more